Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol

被引：3

作者：

Beyer, Katharina ^{[1
]}

Moris, Lisa ^{[2
]}

Lardas, Michael ^{[3
]}

Haire, Anna ^{[1
]}

Barletta, Francesco ^{[4
]}

Scuderi, Simone ^{[4
]}

Vradi, Eleni ^{[5
]}

Gandaglia, Giorgio ^{[4
]}

Omar, Muhammad Imran ^{[6
]}

MacLennan, Steven ^{[6
]}

Zong, Jihong ^{[7
]}

Farahmand, Bahman ^{[8
]}

Maclennan, Sara J. ^{[6
]}

Devecseri, Zsuzsanna ^{[9
]}

Asiimwe, Alex ^{[5
]}

Collette, Laurence ^{[10
]}

Bjartell, Anders ^{[11
]}

Ndow, James ^{[12
]}

Briganti, Alberto ^{[4
,13
,14
]}

Van Hemelrijck, Mieke ^{[1
]}

机构：

[1] Kings Coll London, Translat Oncol & Urol Res Tour, London, England

[2] Katholieke Univ Leuven, Dept Urol, Univ Hosp Leuven, Leuven, Flanders, Belgium

[3] Metropolitan Hosp Athens, Dept Urol, Athens, Attike, Greece

[4] IRCCS Osped San Raffaele, Div Oncol, Unit Urol, URI, Milan, Lombardia, Italy

[5] Bayer Pharma AG, Med Affairs & PV, Berlin, Germany

[6] Univ Aberdeen, Acad Urol Unit, Hlth Serv Res Unit, Aberdeen, Scotland

[7] Bayer US, Epidemiol, Whippany, NJ USA

[8] Bayer AG, Global Epidemiol, Stockholm, Sweden

[9] Sanofi SA, Paris, Ile De France, France

[10] EORTC, Brussels, Belgium

[11] Skane Univ Hosp, Malmo, Sweden

[12] European Assoc Urol, Guidelines Off, Arnhem, Netherlands

[13] Univ Vita Salute San Raffaele, Urol Res Inst, RCCS San Raffaele Sci Inst, Dept Urol, Milan, Italy

[14] Univ Vita Salute San Raffaele, Urol Res Inst, RCCS San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy

来源：

BMJ OPEN | 2021年 / 11卷 / 02期

基金：

欧盟地平线“2020”;

关键词：

prostate disease; oncology; urological tumours; BIAS; RISK; TOOL; APPLICABILITY; PROBAST;

D O I：

10.1136/bmjopen-2020-040531

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction As part of the PIONEER (Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe) Consortium, we will explore which diagnostic and prognostic factors (DPFs) are currently being researched to previously defined clinical and patient-reported outcomes for prostate cancer (PCa). Methods and analysis This research project will follow the following four steps: (1) a broad systematic literature review of DPFs for all stages of PCa, covering evidence from 2014 onwards; (2) discussion of systematic review findings by a multidisciplinary expert panel; (3) risk of bias assessment and applicability with Prediction model Risk Of Bias Assessment Tool criteria, Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) and the Quality In Prognosis Studies tool (QUIPS) and (4) additional quantitative assessments if required. Ethics and dissemination We aim to develop an online tool to present the DPFs identified in this research and make them available across all stakeholders. There are no ethical implications.

引用

页数：5

共 50 条

[1] Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
Beyer, Katharina
Moris, Lisa
Lardas, Michael
Haire, Anna
Barletta, Francesco
Scuderi, Simone
Molnar, Megan
Herrera, Ronald
Rauf, Abdul
Campi, Riccardo
Greco, Isabella
Shiranov, Kirill
Dabestani, Saeed
van den Broeck, Thomas
Arun, Sujenthiran
Gacci, Mauro
Gandaglia, Giorgio
Omar, Muhammad Imran
MacLennan, Steven
Roobol, Monique J.
Farahmand, Bahman
Vradi, Eleni
Devecseri, Zsuzsanna
Asiimwe, Alex
Zong, Jihong
Maclennan, Sara J.
Collette, Laurence
NDow, James
Briganti, Alberto
Bjartell, Anders
Van Hemelrijck, Mieke
[J]. BMJ OPEN, 2022, 12 (04):
[2] Diagnostic and prognostic factors in patients with prostate cancer
Beyer, K.
Moris, L.
Lardas, M.
Haire, A.
Barletta, F.
Scuderi, S.
Molnar, M.
Herrera, R.
Rauf, A.
Campi, R.
Greco, I.
Shiranov, K.
Dabestani, S.
Van den Broeck, T.
Gacci, M.
Gandaglia, G.
Omar, M. I.
Maclennan, S.
Roobol, M. J.
Zong, J.
Maclennan, S. J.
Collette, L.
Briganti, A.
Bjartell, A.
Van Hemelrijck, M.
[J]. EUROPEAN UROLOGY, 2021, 79 : S428 - S429
[3] The prognostic value of sarcopenia in patients with prostate cancer: a systematic review
Jahrreiss, Victoria
Laukhtina, Ekaterina
D'Andrea, David
Shariat, Shahrokh F.
[J]. CURRENT OPINION IN UROLOGY, 2021, 31 (04) : 315 - 323
[4] Prognostic factors of mortality in patients with cancer infected with COVID-19: a systematic review protocol
Han, Mi Ah
Hwang, Eu Chang
Jung, Jae Hung
[J]. BMJ OPEN, 2023, 13 (07):
[5] Prognostic factors in patients with oligometastatic breast cancer - A systematic review
van Ommen-Nijhof, Annemiek
Steenbruggen, Tessa G.
Schats, Winnie
Wiersma, Terry
Horlings, Hugo M.
Mann, Ritse
Koppert, Linetta
van Werkhoven, Erik
Sonke, Gabe S.
Jager, Agnes
[J]. CANCER TREATMENT REVIEWS, 2020, 91
[6] Factors associated with prognostic awareness in patients with cancer: A systematic review
Vlckova, Karolina
Tuckova, Anna
Polakova, Kristyna
Loucka, Martin
[J]. PSYCHO-ONCOLOGY, 2020, 29 (06) : 990 - 1003
[7] Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review
Broseghini, Elisabetta
Filippini, Daria Maria
Fabbri, Laura
Leonardi, Roberta
Abeshi, Andi
Dal Molin, Davide
Fermi, Matteo
Ferracin, Manuela
Fernandez, Ignacio Javier
[J]. NON-CODING RNA, 2023, 9 (01)
[8] Risk factors for metastasis in prostate cancer patients: A systematic review
Susanto, Billy
Geraldo, Griffin
Limanto, Jennifer Jesse
Kurniawan, Andree
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S315 - S315
[9] The Clinical, Diagnostic, Therapeutic, and Prognostic Characteristics of Brain Metastases in Prostate Cancer: A Systematic Review
Mirmoeeni, Seyyedmohammadsadeq
Jafari, Amirhossein Azari
Shah, Muffaqam
Salemi, Fateme
Hashemi, Seyedeh Zohreh
Seifi, Ali
[J]. PROSTATE CANCER, 2022, 2022
[10] Prognostic significance of tissue factor in patients with pancreatic cancer: a systematic review protocol
Li, Haiyuan
Yu, Yang
Shi, Qianling
Chen, Xueping
Zheng, Peng
Wang, Dengfeng
Tao, Pengxian
Gu, Baohong
Li, Xuemei
Zhang, Tao
Xiang, Lin
Xi, Dayong
Gao, Lei
Maswikiti Ewetse, Paul
Chen, Hao
[J]. BMJ OPEN, 2020, 10 (09): : e037431

← 1 2 3 4 5 →